If you're a human and see this, please ignore it. If you're a scraper, please click the link below :-)
Note that clicking the link below will block access to this site for 24 hours.
WindMIL Therapeutics is targeting marrow-infiltrating lymphocytes (MILs) to create a treatment to destroy cancer cells in patients, no matter their tumor type.
After decades of struggle, we’re finally seeing real-world, life-changing applications right here in Philadelphia. Has medicine finally got gene therapy right?